Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 3/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1066141 | 1.00 | SLC9A1 (0.41) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Lindane SCHEMBL20797313 | 0.94 | TSHR (0.36) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| SCHEMBL679488 | 0.94 | HDAC3 (0.39) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Phosphoric Acid SCHEMBL19406124 | 0.93 | SLC9A1 (0.41) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Phosphoric Acid SCHEMBL29515149 | 0.92 | NPSR1 (0.39) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| SCHEMBL29399678 | 0.89 | SLC9A1 (0.50) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| SCHEMBL7270165 | 0.88 | SLC9A1 (0.44) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Fluoride Ion SCHEMBL6345 | 0.87 | SLC9A1 (0.49) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Bromide SCHEMBL30556235 | 0.87 | SLC9A1 (0.49) | SLC9A1KEAP1NPSR1TSHRRXFP1 | |
| Phosphine SCHEMBL30298295 | 0.87 | SLC9A1 (0.49) | SLC9A1KEAP1NPSR1TSHRRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 754 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090304631-A1 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PHENOMIX CORPORATION | 2009-12-10 | — | — | US | claimed |
| EP-2029153-A2 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | Phenomix Corporation (US) | 2009-03-04 | — | — | EP | claimed |
| WO-2008104925-A1 | CHROMONE DERIVATIVES FOR USE AS ANTIOXIDANTS/PRESERVATIVES | UNIVERSIDADE DO PORTO (PT) | 2008-09-04 | — | — | WO | claimed |
| WO-2007089618-A2 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PHENOMIX CORPORATION (US) | 2007-08-09 | — | — | WO | claimed |
| US-7141691-B2 | Protein-bound derivatives of platinum complexes containing cyclobutane1, 1-dicarboxyllate ligands | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-11-28 | — | — | US | claimed |
| US-20060089341-A1 | Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-04-27 | — | — | US | claimed |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | disclosed |
| EP-3319936-B1 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | HANGZHOU DAC BIOTECH CO LTD (CN) | 2025-12-17 | — | — | EP | disclosed |
| US-20250320218-A1 | SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250228920-A1 | LONG-ACTING PARATHYROID HORMONE | EXTEND BIOSCIENCES, INC. (US) | 2025-07-17 | — | — | US | disclosed |
| EP-4217346-B1 | NEW COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2025-07-02 | — | — | EP | disclosed |
| US-20250197369-A1 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2025-06-19 | — | — | US | disclosed |
| EP-4567028-A1 | PHTHALAZINONE DERIVATIVES AS NLRP3 INFLAMMASOME INHIBITORS | JANSSEN Pharmaceutica NV (BE) | 2025-06-11 | — | — | EP | disclosed |
| US-5104869-A | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1992-04-14 | — | — | US | disclosed |
| WO-1992001713-A1 | PEPTIDES AND ANALOGUES AND MIXTURES THEREOF FOR DETECTING ANTIBODIES TO HTLV-I AND HTLV-II VIRUSES | BIOCHEM PHARMA INC. (CA) | 1992-02-06 | — | — | WO | disclosed |
| EP-0427939-A2 | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1991-05-22 | — | — | EP | disclosed |
| WO-1991002748-A1 | RUBELLA E1 PEPTIDES | IAF BIOCHEM INTERNATIONAL INC. (CA) | 1991-03-07 | — | — | WO | disclosed |
| US-4965343-A | COUPLING SIDE-CHAIN UNPROTECTED HYDROXYAMINO ACIDS TO PEPTIDE CHAIN USING BENZOTRIAZOL-1-YL-OXY-TRIS-(DIMETHYL)-OXY-TRIS-(DIMETHYL)-PHOSPHONIUM HEXAFLUOROPHOSPHATE | HOFFMANN-LA ROCHE INC. (US) | 1990-10-23 | — | — | US | disclosed |
| WO-1990000399-A1 | RETROVIRAL PROTEASE BINDING PEPTIDES | SMITHKLINE BECKMAN CORPORATION (US) | 1990-01-25 | — | — | WO | disclosed |
| EP-0352000-A2 | Retroviral protease binding peptides | SMITHKLINE BEECHAM CORPORATION (US) | 1990-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197369-A1 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | HDAC1, HDAC6, HDAC5 | SLC9A1 2925/4885KEAP1 202/4885NPSR1 4656/4885 |
| US-20060089341-A1 | Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands | DDB1, DCLRE1A, PDCD1LG2 | SLC9A1 1468/4885KEAP1 1404/4885NPSR1 4033/4885 |
| US-20250228920-A1 | LONG-ACTING PARATHYROID HORMONE | PTH1R, VDR, CYP24A1 | SLC9A1 2701/4885KEAP1 3906/4885NPSR1 209/4885 |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | STING1, CGAS, IRF3 | SLC9A1 1066/4885KEAP1 267/4885NPSR1 3277/4885 |
| US-20090304631-A1 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PREP, CTSC, PEPD | SLC9A1 3069/4885KEAP1 729/4885NPSR1 2030/4885 |
| US-20250320218-A1 | SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | HRH4, HRH3, HRH2 | SLC9A1 637/4885KEAP1 1926/4885NPSR1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.